Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway

Caveolin 1:PP2A/ATM/p53 通路的新型调节剂

基本信息

项目摘要

DESCRIPTION (provided by applicant): One of the manifestations of aging is the accumulation of damage at both cellular and organism levels. Genotoxic stress plays an important role in aging and age-related diseases such as emphysema, which is caused by a failure of lung maintenance and repair after sustained oxidative stress. Cigarette smoke represents a source of oxidants and is considered an environmental hazard that causes pulmonary emphysema. Premature senescence is believed to contribute to genotoxic stress-induced emphysema. The tumor suppressor protein p53 is a key regulator of premature senescence and is activated by the ataxia-telangiectasia mutated (ATM) protein kinase when the ATM inhibitor protein phosphatase 2A (PP2A) dissociates from ATM after genotoxic stress. The mechanism underlying PP2A-C removal from ATM upon genotoxic stress remains totally unexplored. In addition, the role that the ATM/p53 pathway plays in cigarette smoke-induced cellular senescence and the pathogenesis of emphysema remains largely unknown. Here, we plan to test the hypothesis that the lipid raft protein caveolin-1 mediates stress-induced premature senescence by promoting ATM-dependent activation of p53 through sequestration of the ATM inhibitor PP2A-C into caveolae. In addition, it is hypothesized that caveolin-1 plays a central role in oxidant-promoted emphysema in vivo through induction of cellular senescence. This hypothesis will be tested by pursuing three specific aims: Specific Aim 1: Investigate the role of caveolin-1 in PP2A-mediated regulation of ATM function after genotoxic stress. Specific Aim 2: Determine the functional consequences of loss of caveolin-1 expression on ATM-mediated p53 activation and premature senescence. Specific Aim 3: Define the role of caveolin-1 in genotoxic stress-induced pulmonary emphysema in vivo. These studies will provide novel insights into the signaling machinery that links genotoxic stress to cellular senescence and propose caveolin-1 as a novel therapeutic target for the treatment of age-related diseases such as emphysema. PUBLIC HEALTH RELEVANCE: Oxidative stress, including cigarette smoke, promotes premature cellular senescence, which is believed to have an important role in the more complicated aging process, and contributes to age-related diseases like emphysema. The molecular mechanisms underlying cigarette smoke-induced emphysema are not fully understood. Our studies will test the hypothesis that the protein caveolin-1 is a novel regulator of stress-induced cellular senescence and emphysema, and propose caveolin-1 as an alternative therapeutic target for the treatment of age-related diseases such as emphysema.
描述(由申请人提供):衰老的表现之一是在细胞和生物水平上均积累损害。遗传毒性应激在衰老和与年龄有关的疾病(例如肺气肿)中起重要作用,这是由于持续的氧化应激后肺部维持和修复失败引起的。香烟烟代表氧化剂的来源,被认为是导致肺气肿的环境危害。据信过早衰老有助于遗传毒性应激诱导的肺气肿。肿瘤抑制蛋白p53是过早衰老的关键调节剂,当ATM抑制剂蛋白磷酸酶2A(PP2A)在遗传毒性应激后与ATM分离时,被共济型 - 催化性突变(ATM)蛋白激酶激活。在遗传毒性应力下,从ATM中去除PP2A-C的基础机制仍然完全没有探索。另外,ATM/p53途径在香烟烟雾诱导的细胞衰老和肺气肿的发病机理中发挥作用。在这里,我们计划检验以下假设:脂质筏蛋白可窝蛋白-1通过通过固并ATM抑制剂PP2A-C中的ATM依赖性激活p53促进压力诱导的过早衰老。此外,假设小窝蛋白1通过诱导细胞衰老而在体内氧化剂促进性肺气肿中起着核心作用。该假设将通过追求三个特定目的来检验:特定目的1:研究小窝蛋白1在遗传毒性应激后对ATM功能调节的作用。具体目标2:确定在ATM介导的p53激活和早衰老中,小窝蛋白-1表达丧失的功能后果。具体目标3:定义小窝蛋白-1在体内遗传毒性应激诱导的肺肺气肿中的作用。这些研究将提供有关将遗传毒性应激与细胞衰老联系起来的信号机械的新见解,并提出小窝蛋白-1作为治疗与年龄相关疾病(如肺气肿)的新型治疗靶标。公共卫生相关性:包括香烟烟雾在内的氧化应激会促进过早的细胞衰老,据信这在更复杂的衰老过程中起着重要作用,并有助于与年龄相关的疾病,例如肺气肿。香烟烟雾引起的肺气肿的分子机制尚不完全了解。我们的研究将检验以下假设:蛋白质可窝蛋白-1是应激诱导的细胞衰老和肺气肿的新型调节剂,并提出小窝蛋白-1作为治疗年龄相关疾病(如肺气肿)的替代治疗靶标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FERRUCCIO GALBIATI其他文献

FERRUCCIO GALBIATI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FERRUCCIO GALBIATI', 18)}}的其他基金

Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9305499
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9459856
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9899946
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    9279206
  • 财政年份:
    2015
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    9059176
  • 财政年份:
    2015
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    8903586
  • 财政年份:
    2014
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8507585
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8114097
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8301580
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    7574065
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:

相似国自然基金

TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
  • 批准号:
    82220108016
  • 批准年份:
    2022
  • 资助金额:
    252 万元
  • 项目类别:
    国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81800806
  • 批准年份:
    2018
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81700824
  • 批准年份:
    2017
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
  • 批准号:
    81670269
  • 批准年份:
    2016
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
  • 批准号:
    31470998
  • 批准年份:
    2014
  • 资助金额:
    87.0 万元
  • 项目类别:
    面上项目

相似海外基金

The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 30.25万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 30.25万
  • 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
  • 批准号:
    10465010
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
  • 批准号:
    10555899
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了